Showing results (81-90 of 1,897) with videos related to

Sort By:
Pageof 190
Open Heart|November 30, 2018
Pre-test characteristics of unstable angina patients with obstructive coronary artery disease confirmed by coronary angiographyKristina Fladseth, Andreas Kristensen, Jan Mannsverk, et al.
Open Heart|November 30, 2018
Intermittent systemic hypoxic-hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trialDenis S Tuter, Philippe Y Kopylov, Abram L Syrkin, et al.
Open Heart|January 8, 2019
Exercise-based cardiac rehabilitation improves exercise capacity and health-related quality of life in people with atrial fibrillation: a systematic review and meta-analysis of randomised and non-randomised trialsNeil A Smart, Nicola King, Jeffrey D Lambert, et al.
Open Heart|January 8, 2019
Duration of myocardial early systolic lengthening for diagnosis of coronary artery diseaseMasatoshi Minamisawa, Jun Koyama, Ayako Kozuka, et al.
Open Heart|January 8, 2019
Quantitative assessment of pericardial delayed hyperenhancement helps identify patients with ongoing recurrences of pericarditisArnav Kumar, Kimi Sato, Beni Rai Verma, et al.
Open Heart|December 12, 2017
Immediate response in markers of inflammation and angiogenesis during exercise: a randomised cross-over study in heart transplant recipientsMarianne Yardley, Thor Ueland, Pål Aukrust, et al.
Open Heart|March 14, 2018
Direct oral anticoagulants versus warfarin: is new always better than the old?John Burn, Munir Pirmohamed
Open Heart|March 14, 2018
Associations between cardiac troponin, mortality and subsequent use of cardiovascular services: differences in sex and ethnicityDavid E Winchester, Kristopher Kline, Christopher Estel, et al.
Open Heart|March 14, 2018
Repetitive squatting exercise as a diagnostic predictor in patients with dilated cardiomyopathyKrunoslav Michael Sveric, Stefan Ulbrich, Mohamed Rady, et al.
Open Heart|March 14, 2018
Rationale and design of the ranolazine PH-RV study: a multicentred randomised and placebo-controlled study of ranolazine to improve RV function in patients with non-group 2 pulmonary hypertensionYuchi Han, Paul R Forfia, Anjali Vaidya, et al.
Pageof 190